A validated size exclusion chromatography method coupled with fluorescence detection for rapid quantification of bevacizumab in ophthalmic formulations
Bevacizumab is a full-length human monoclonal antibody used to treat various neovascular diseases such as wet age-related macular degeneration (AMD), diabetic eye disease and other problems of the retina. Monthly intravitreal injections of bevacizumab (Avastin®) are effective in the treatment of wet...
| Published in: | Journal of Pharmaceutical and Biomedical Analysis |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier B.V.
2019
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066322059&doi=10.1016%2fj.jpba.2019.05.038&partnerID=40&md5=d6c196af7aefc5472cc4c5c39e2eff5e |